Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
150 mg Usnoflast[1] Usnoflast (Usnoflast)[1] Usnoflast (Usnoflast) 💬 [1] NLRP3 💬 [12] C-type lectin receptor signaling pathway, Coronavirus disease, Cytosolic DNA-sensing pathway, Influenza A, Lipid and atherosclerosis, NOD-like receptor signaling pathway, Necroptosis, Pathogenic Escherichia coli infection, Pertussis, Salmonella infection, Shigellosis, Yersinia infection 💬[1] 2 💬
275 mg Usnoflast[1] Usnoflast (Usnoflast)[1] Usnoflast (Usnoflast) 💬 [1] NLRP3 💬 [12] C-type lectin receptor signaling pathway, Coronavirus disease, Cytosolic DNA-sensing pathway, Influenza A, Lipid and atherosclerosis, NOD-like receptor signaling pathway, Necroptosis, Pathogenic Escherichia coli infection, Pertussis, Salmonella infection, Shigellosis, Yersinia infection 💬[1] 2 💬
3Usnoflast[1] Usnoflast (Usnoflast)[1] Usnoflast (Usnoflast) 💬 [1] NLRP3 💬 [12] C-type lectin receptor signaling pathway, Coronavirus disease, Cytosolic DNA-sensing pathway, Influenza A, Lipid and atherosclerosis, NOD-like receptor signaling pathway, Necroptosis, Pathogenic Escherichia coli infection, Pertussis, Salmonella infection, Shigellosis, Yersinia infection 💬[1] 2 💬